-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIDGEBIO PHARMA: LAUNCH OF SECONDARY PUBLIC OFFERING OF 5 MLN SHARES OF COMMON STOCK BY SELLING STOCKHOLDER KKR GENETIC DISORDER L.P

Reuters·08/13/2026 21:43:03

Please log in to view news